Leprosy recurrences in the Astrakhan region (1951–2020): a long-term analysis of incidence, risk factors, and treatment outcomes
Annals of the Russian academy of medical sciences · 19.06.2026 · 81 (2) · 146-152
DOI: 10.15690/vramn18182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Russian academy of medical sciences, online erschienen am 19.06.2026. Verfasst von Elena Yu. Yanchevskaya und 2 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Background
Despite significant progress in controlling leprosy incidence, the problem of relapses remains relevant, especially in endemic regions. Analysis of long-term dynamics of relapses and factors influencing their development is necessary to optimize treatment tactics and follow-up observation. Aims — to study the frequency, structure and risk factors for leprosy relapses based on a 70-year retrospective observation, to evaluate the evolution of therapeutic approaches and their impact on disease recurrence.
Methods
A retrospective continuous cohort study was conducted. We analyzed 1165 medical records of patients with verified leprosy registered at the Astrakhan Leprosy Dispensary in 1951–2020. A total of 465 relapse cases (1959–2019) were studied. The association of relapses with the clinical form, type of therapy and duration of remission was assessed. Descriptive statistics, χ² test and multivariate logistic regression analysis were used.
Results
The dynamics of relapses had three periods: a high frequency period in the era of dapsone monotherapy (1959–1976; 297 cases; 63.9%); a steady decline period with the introduction of combined therapy (1977–1990; 80 cases; 17.2%); a period of sporadic relapses (1991–2019; 88 cases; 18.9%) with near-complete elimination after 2008 (3 cases). It was found that 68.8% of relapses developed in patients with an initial multibacillary (MB) form of leprosy. Multivariate analysis identified independent risk factors: MB form (OR — 4.8; 95% CI: 3.2–7.1; p 0.001), dapsone monotherapy (OR — 6.2; 95% CI: 4.1–9.3; p 0.001), irregular/incomplete treatment (OR — 3.9; 95% CI: 2.5–6.1; p 0.001), and high bacterial index (OR — 5.3; 95% CI: 3.4–8.2; p 0.001).
Conclusions
The problem of leprosy relapses in modern conditions has been solved due to the transition to standardized WHO multidrug therapy. The key risk factor is the MB form. The obtained data substantiate the need for differentiated follow-up observation of patients depending on the initial clinical form and received therapy.
Zitieren
APA
Yanchevskaya, E. Y., Serdyukov, A. G., & Voronina, L. P. (2026). Leprosy recurrences in the Astrakhan region (1951–2020): a long-term analysis of incidence, risk factors, and treatment outcomes. Annals of the Russian academy of medical sciences, 81(2), 146-152. https://doi.org/10.15690/vramn18182
Vancouver
Yanchevskaya EY, Serdyukov AG, Voronina LP. Leprosy recurrences in the Astrakhan region (1951–2020): a long-term analysis of incidence, risk factors, and treatment outcomes. Annals of the Russian academy of medical sciences. 2026;81(2):146-152. doi:10.15690/vramn18182
BibTeX
@article{Yanchevskaya2026,
author = {Yanchevskaya, Elena Yu. and Serdyukov, Anatoly G. and Voronina, Lyudmila P.},
title = {Leprosy recurrences in the Astrakhan region (1951–2020): a long-term analysis of incidence, risk factors, and treatment outcomes},
journal = {Annals of the Russian academy of medical sciences},
year = {2026},
volume = {81},
number = {2},
pages = {146--152},
doi = {10.15690/vramn18182}
}
EUVIMED